Moreover, Slc39a5-/-; Lepr-/- mice displayed reduced NAFLD activity score (an aggregate score of macrovesicular steatosis, hepatocellular hypertrophy, and inflammation) (Figure 4E and Figure 4—figure supplement 1E). This evidence concerns the gene SLC39A5 and steatosis.